MapLight Therapeutics (MPLT) Net Cash Flow (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Net Cash Flow came in at -$17.4 million in Q4 2025, down 259.63% year-on-year from $10.9 million in Q4 2024, and down 259.63% quarter-over-quarter from $10.9 million in Q4 2024.
MapLight Therapeutics (MPLT) Net Cash Flow (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Net Cash Flow across 2 years of filings, most recently posting -$17.4 million for Q4 2025.
- Net Cash Flow for Q4 2025 came in at -$17.4 million, down 259.63% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.5 million (changed N/A YoY), and the FY2025 annual result was $8.5 million, up 120.4% from the prior year.
- Net Cash Flow came in at -$17.4 million for Q4 2025 at MapLight Therapeutics, down from $10.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $10.9 million in Q4 2024 to a low of -$17.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | -17.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.42 Mn |
| Dec 31, 2025 | -17.42 Mn |
| Dec 31, 2024 | 10.91 Mn |
| Dec 31, 2024 | 10.91 Mn |